Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
AI is now a core part of business strategy, and leaders who understand how to use it can make faster decisions, drive ...
Commenting on the Challenger gravity survey, Barton Managing Director Alexander Scanlon said: "With a DFS underway for the ...
TipRanks on MSN
NAXS expands share buyback program to enhance capital structure and shareholder value
NAXS AB ( ($SE:NAXS) ) has shared an announcement. NAXS AB has repurchased 6,807 of its own shares on Nasdaq Stockholm between 15 and 19 December ...
How Carleton is using simulation and visualization to improve training, design and human performance
At Carleton University, researchers are addressing a growing demand for advanced systems that enable learners to practice ...
Our review of Bay Area data shows that although San Francisco ranks high for social capital, there are significant variations ...
Islands.com on MSN
Europe's 13 Most Peaceful Countries, Per A Study
According to the Global Peace Index, these 13 countries in Europe are the most peaceful in the continent and among the most ...
North Carolina ranks in the top states for homeschooling because it provides freedom and structure, said Jessica Frierson of ...
The bureau is accelerating a global biometric screening architecture that is designed to identify and disrupt individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback